Last week, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Type 2 diabetes. Called Cycloset, the drug is actually a new version of the older drug bromocriptine, which has been used at higher doses to treat people with Parkinson disease.
On April 30, Disetronic Medical Systems, Inc. (a division of Roche) announced a recall of certain Accu-Chek Spirit insulin pumps due to a manufacturing problem: These pumps may be at risk of having their "up" and/or "down" buttons fail with repeated use. Pumps with serial numbers ranging from SN02119552 to SN10006093, which were shipped in the United States, are affected by this recall.
If you’ve been reading, watching, or listening to the news over the last week, you’ve probably heard about the cases of H1N1 influenza (or "swine flu") that have broken out in Mexico and in a few locations in the United States and other parts of the world. On April 29, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 5, sending a "strong signal that a pandemic is imminent and that the time to finalize the organization, communication, and implementation of the planned mitigation measures is short." In other words, more cases may be on the way.